Overview
Lobbying Costs
150,000€
Financial year: Jan 2015 - Dec 2015
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Mylan GmbH (Mylan)
EU Transparency Register
940251520152-08 First registered on 04 Jan 2016
Goals / Remit
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. Our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time.
Main EU files targeted
ATMP Regulation
Clinical Trials Regulation
Data Protection Regulation
Medical Devices Regulation
In-Vitro Diagnostic Regulation
Paediatric Regulation
Access to Innovation
Biosimilars
Industrial Policy
EU Trade Policy
Health Systems Performance Assessment
Health Technology Assessment
Pharmaceuticals in the environmentAddress
Head Office
Thurgauerstrasse 40
Zurich 8050
SWITZERLANDEU Office
Square de Meeus 37
Brussels 1000
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 13 Dec 2016
Name Start date End Date Daryl Melissa ALVAREZ VILLAO 17 Feb 2024 14 Feb 2025 Katarina GATIALOVA 29 Feb 2024 28 Feb 2025 Mr David DELANEY 02 Mar 2023 11 Mar 2024 Daryl Melissa ALVAREZ VILLAO 28 Jan 2023 27 Jan 2024 Mr Victor Lino MENDONCA 26 Jan 2023 26 Jan 2024 Katarina GATIALOVA 26 Jan 2023 26 Jan 2024 Katarina GATIALOVA 19 Nov 2021 19 Nov 2022 Mr David DELANEY 13 Oct 2021 13 Oct 2022 Katarina GATIALOVA 06 Feb 2020 06 Feb 2021 Mr Victor Lino MENDONCA 07 Jan 2020 07 Jan 2021 Mr David DELANEY 25 Sep 2019 25 Sep 2020 Katarina GATIALOVA 29 Jan 2019 01 Feb 2020 Mr Victor Lino MENDONCA 30 Nov 2018 30 Nov 2019 Mr David DELANEY 13 Jul 2018 13 Jul 2019 Mr Paulo Jorge RODRIGUES FRANCO MENDES 29 May 2018 31 Oct 2018 Complementary Information
None declared
Person in charge of EU relations
Mr Victor Mendonca (Head of Policy & Market Access - Europe)
Person with legal responsibility
Mr Jacek Glinka (President Mylan Europe)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Medicines for Europe (MfE)
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2015 - Dec 2015
Lobbying costs for closed financial year
150,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
None
Other activities
At European level, Mylan is committed to working in partnership with the institutions of the European Union to support policies and actions that foster positive patient outcomes and high quality medicines for all.
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 05 Jun 2023 Location Brussels Subject Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Zaneta Vegnere (Cabinet member)
- Elina Melngaile (Cabinet member)
Other Lobbyists - John Deere GmbH&Co.Kg
- Dow Europe GmbH
- IBM Corporation
- ConocoPhillips
- Shopify Inc.
- AIG Europe S.A.
- AbbVie
- Chamber of Commerce of the United States of America
- Pharmaceutical Research and Manufacturers of America
- Intel Corporation
- Boeing International Corporation - Belgium Branch Office
- Abbott
- Merck
- American Chamber of Commerce to the European Union
- Micron Technology Inc.
- Meetings